Publications Breadcrumb Home Publications Since we carefully research publications with DZIF affiliation before posting them on the DZIF website, there is usually a delay of two to three months between a paper's publication date and its listing on the DZIF publications website. Show filterHide filter All years of publication All years of publication20122013201420152016201720182019202020212022202320242025 All research areas All research areasCommunity-Acquired Infections at Mucosal InterfacesHepatitisHIVInfections of the Immunocompromised HostHealthcare-Associated InfectionsMalaria and Neglected Tropical DiseasesEmerging InfectionsNovel AntibioticsTuberculosis All infrastructures All infrastructuresBioresources, Biodata and Digital HealthDZIF AcademyClinical Trial UnitProduct Development Aug 2014 Nature Pre-Columbian mycobacterial genomes reveal seals as a source of New World human tuberculosis Autoren Bos KI et al. Aug 2014 J Immunol The N-terminal domain of NLRC5 confers transcriptional activity for MHC class I and II gene expression Autoren Neerincx A et al. Aug 2014 Antimicrob Agents Chemother Antimalarial activity of the myxobacterial macrolide chlorotonil a Autoren Held J et al. Aug 2014 Int J Syst Evol Microbiol Minicystis rosea gen. nov., sp. nov., a polyunsaturated fatty acid-rich and steroid-producing soil myxobacterium Autoren Garcia R Gemperlein K Müller R Aug 2014 Antimicrob Agents Chemother Overproduction of Ristomycin A by activation of a silent gene cluster in Amycolatopsis japonicum MG417-CF17 Autoren Spohn M et al. Aug 2014 J Antimicrob Chemother A multicentre cohort study on colonization and infection with ESBL-producing Enterobacteriaceae in high-risk patients with haematological malignancies Autoren Vehreschild MJ et al. Aug 2014 Cytotherapy Clinical-scale isolation of 'minimally manipulated' cytomegalovirus-specific donor lymphocytes for the treatment of refractory cytomegalovirus disease Autoren Odendahl M et al. Aug 2014 Trends Pharmacol Sci New pharmacological strategies to fight enveloped viruses Autoren Wisskirchen K et al. Aug 2014 Nature Antiviral immunity via RIG-I-mediated recognition of RNA bearing 5′-diphosphates Autoren Goubau D et al. Aug 2014 J Biotechnol A highly unusual polyketide synthase directs dawenol polyene biosynthesis in Stigmatella aurantiaca Autoren Oßwald C et al. Aug 2014 Dig Liver Dis A farnesoid X receptor polymorphism predisposes to spontaneous bacterial peritonitis Autoren Lutz P et al. Aug 2014 Am J Respir Crit Care Med As galactomannan disappoints, our quest for a feasible diagnostic standard for invasive aspergillosis continues Autoren Vehreschild JJ Aug 2014 PLoS Negl Trop Dis Seroprevalence of alphavirus antibodies in a cross-sectional study in southwestern Tanzania suggests endemic circulation of chikungunya Autoren Weller N et al. Jul 2014 Proc Natl Acad Sci U S A Effective treatment of allergic airway inflammation with Helicobacter pylori immunomodulators requires BATF3-dependent dendritic cells and IL-10 Autoren Engler DB et al. Jul 2014 Eur J Gastroenterol Hepatol High prevalence of hepatitis markers in immigrant populations: a prospective screening approach in a real-world setting Autoren Heidrich B et al. Jul 2014 PLoS One Anti-HDV IgM as a marker of disease activity in hepatitis delta Autoren Wranke A et al. Jul 2014 J Virol Characterization of the mode of action of a potent dengue virus capsid inhibitor Autoren Scaturro P et al. Jul 2014 Antiviral Res Development of a high-throughput pyrosequencing assay for monitoring temporal evolution and resistance associated variant emergence in the Hepatitis C virus protease coding-region Autoren Irving WL et al. Jul 2014 Lancet Infect Dis HEV-associated cryoglobulinaemia and extrahepatic manifestations of hepatitis E Autoren Pischke S et al. Jul 2014 Gastroenterology Daclatasvir-like inhibitors of NS5A block early biogenesis of hepatitis C virus-induced membranous replication factories, independent of RNA replication Autoren Berger C et al. Jul 2014 Febs j From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design Autoren Hilgenfeld R Jul 2014 Lancet Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013 Autoren Murray CJL et al. Jul 2014 J Viral Hepat Peginterferon-alfa mono-therapy in the treatment of acute hepatitis C in HIV-infection Autoren Boesecke C et al. Jul 2014 Intervirology Molecular virology of hepatitis B virus and targets for antiviral intervention Autoren Glebe D König A Jul 2014 Intervirology Selected phenotypic assays used to evaluate antiviral resistance and viral fitness of hepatitis B virus and its variants Autoren Glebe D Geipel A Pagination Previous page ‹‹ Seite 267 Seite 268 Seite 269 Seite 270 Current page 271 Seite 272 Seite 273 Seite 274 Seite 275 Seite 267 Seite 268 Seite 269 Seite 270 Seite 271 Seite 272 Seite 273 Seite 274 Seite 275 Next page ››
Aug 2014 Nature Pre-Columbian mycobacterial genomes reveal seals as a source of New World human tuberculosis Autoren Bos KI et al.
Aug 2014 J Immunol The N-terminal domain of NLRC5 confers transcriptional activity for MHC class I and II gene expression Autoren Neerincx A et al.
Aug 2014 Antimicrob Agents Chemother Antimalarial activity of the myxobacterial macrolide chlorotonil a Autoren Held J et al.
Aug 2014 Int J Syst Evol Microbiol Minicystis rosea gen. nov., sp. nov., a polyunsaturated fatty acid-rich and steroid-producing soil myxobacterium Autoren Garcia R Gemperlein K Müller R
Aug 2014 Antimicrob Agents Chemother Overproduction of Ristomycin A by activation of a silent gene cluster in Amycolatopsis japonicum MG417-CF17 Autoren Spohn M et al.
Aug 2014 J Antimicrob Chemother A multicentre cohort study on colonization and infection with ESBL-producing Enterobacteriaceae in high-risk patients with haematological malignancies Autoren Vehreschild MJ et al.
Aug 2014 Cytotherapy Clinical-scale isolation of 'minimally manipulated' cytomegalovirus-specific donor lymphocytes for the treatment of refractory cytomegalovirus disease Autoren Odendahl M et al.
Aug 2014 Trends Pharmacol Sci New pharmacological strategies to fight enveloped viruses Autoren Wisskirchen K et al.
Aug 2014 Nature Antiviral immunity via RIG-I-mediated recognition of RNA bearing 5′-diphosphates Autoren Goubau D et al.
Aug 2014 J Biotechnol A highly unusual polyketide synthase directs dawenol polyene biosynthesis in Stigmatella aurantiaca Autoren Oßwald C et al.
Aug 2014 Dig Liver Dis A farnesoid X receptor polymorphism predisposes to spontaneous bacterial peritonitis Autoren Lutz P et al.
Aug 2014 Am J Respir Crit Care Med As galactomannan disappoints, our quest for a feasible diagnostic standard for invasive aspergillosis continues Autoren Vehreschild JJ
Aug 2014 PLoS Negl Trop Dis Seroprevalence of alphavirus antibodies in a cross-sectional study in southwestern Tanzania suggests endemic circulation of chikungunya Autoren Weller N et al.
Jul 2014 Proc Natl Acad Sci U S A Effective treatment of allergic airway inflammation with Helicobacter pylori immunomodulators requires BATF3-dependent dendritic cells and IL-10 Autoren Engler DB et al.
Jul 2014 Eur J Gastroenterol Hepatol High prevalence of hepatitis markers in immigrant populations: a prospective screening approach in a real-world setting Autoren Heidrich B et al.
Jul 2014 PLoS One Anti-HDV IgM as a marker of disease activity in hepatitis delta Autoren Wranke A et al.
Jul 2014 J Virol Characterization of the mode of action of a potent dengue virus capsid inhibitor Autoren Scaturro P et al.
Jul 2014 Antiviral Res Development of a high-throughput pyrosequencing assay for monitoring temporal evolution and resistance associated variant emergence in the Hepatitis C virus protease coding-region Autoren Irving WL et al.
Jul 2014 Lancet Infect Dis HEV-associated cryoglobulinaemia and extrahepatic manifestations of hepatitis E Autoren Pischke S et al.
Jul 2014 Gastroenterology Daclatasvir-like inhibitors of NS5A block early biogenesis of hepatitis C virus-induced membranous replication factories, independent of RNA replication Autoren Berger C et al.
Jul 2014 Febs j From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design Autoren Hilgenfeld R
Jul 2014 Lancet Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013 Autoren Murray CJL et al.
Jul 2014 J Viral Hepat Peginterferon-alfa mono-therapy in the treatment of acute hepatitis C in HIV-infection Autoren Boesecke C et al.
Jul 2014 Intervirology Molecular virology of hepatitis B virus and targets for antiviral intervention Autoren Glebe D König A
Jul 2014 Intervirology Selected phenotypic assays used to evaluate antiviral resistance and viral fitness of hepatitis B virus and its variants Autoren Glebe D Geipel A
